{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:56:00Z","timestamp":1794369360423,"version":"4.9.0"},"reference-count":14,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2018,7,4]]},"DOI":"10.1080\/03009742.2017.1390605","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T16:07:07Z","timestamp":1519142827000},"page":"276-281","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":37,"title":["Secukinumab after anti-tumour necrosis factor-\u03b1 therapy: a phase III study in active rheumatoid arthritis"],"prefix":"10.1080","volume":"47","author":[{"given":"E","family":"Dokoupilov\u00e1","sequence":"first","affiliation":[{"name":"Medical Plus, s.r.o., Uherske Hradiste, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Aelion","sequence":"additional","affiliation":[{"name":"Jackson Arthritis Clinic, and Health Science Center, University of Tennessee, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Malavolta","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Division of Internal Medicine, St Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PP","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wang","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rohrer","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HB","family":"Richards","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204573"},{"key":"CIT0003","unstructured":"Biogen Idec Inc. and Genentech, Inc. Rituximab Prescribing Information. Secondary Rituximab prescribing information (http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/103705s5311lbl.pdf). Accessed 25 October 2017."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.10.6015"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/art.22025"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.105197"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209821"},{"key":"CIT0008","unstructured":"Novartis Pharmaceuticals Corporation. Highlights of Prescribing Information. Secondary Highlights of prescribing information (https:\/\/www.pharma.us.novartis.com\/product\/pi\/pdf\/cosentyx.pdf). Accessed 25 October 2017."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/art.40070"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0086-y"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61134-5"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412679"}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03009742.2017.1390605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T22:48:28Z","timestamp":1598741308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03009742.2017.1390605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7,4]]}},"alternative-id":["10.1080\/03009742.2017.1390605"],"URL":"https:\/\/doi.org\/10.1080\/03009742.2017.1390605","relation":{},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irhe20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irhe20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}